Echo Therapeutics Stock Net Income
Echo Therapeutics fundamentals help investors to digest information that contributes to Echo Therapeutics' financial success or failures. It also enables traders to predict the movement of Echo Stock. The fundamental analysis module provides a way to measure Echo Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Echo Therapeutics stock.
Echo |
Echo Therapeutics Company Net Income Analysis
Echo Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Echo Therapeutics Net Income | (12.5 M) |
Most of Echo Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Echo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Echo Therapeutics reported net income of (12.5 Million). This is 103.66% lower than that of the Healthcare sector and 105.25% lower than that of the Medical Devices industry. The net income for all United States stocks is 102.19% higher than that of the company.
Echo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Echo Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Echo Therapeutics could also be used in its relative valuation, which is a method of valuing Echo Therapeutics by comparing valuation metrics of similar companies.Echo Therapeutics is currently under evaluation in net income category among related companies.
Echo Fundamentals
| Return On Equity | -3.65 | |||
| Return On Asset | -359.77 | |||
| Current Valuation | 3.43 M | |||
| Shares Outstanding | 12 M | |||
| Number Of Shares Shorted | 273.27 K | |||
| Price To Earning | (0.03) X | |||
| Price To Book | 3.11 X | |||
| Price To Sales | 990.09 X | |||
| Revenue | 5.12 K | |||
| Gross Profit | 5.12 K | |||
| EBITDA | (5.18 M) | |||
| Net Income | (12.5 M) | |||
| Cash And Equivalents | 172.72 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 3.52 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 0.05 X | |||
| Book Value Per Share | (0.55) X | |||
| Cash Flow From Operations | (4.82 M) | |||
| Short Ratio | 3.40 X | |||
| Earnings Per Share | (1.10) X | |||
| Number Of Employees | 19 | |||
| Beta | 6.99 | |||
| Market Capitalization | 48.02 K | |||
| Total Asset | 805.09 K | |||
| Retained Earnings | (145.78 M) | |||
| Working Capital | (2.93 M) | |||
| Current Asset | 300.74 K | |||
| Current Liabilities | 3.24 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Echo Stock
If you are still planning to invest in Echo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Echo Therapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |